Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2006-04-24
2009-02-17
Zeman, Robert A (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C530S350000
Reexamination Certificate
active
07491398
ABSTRACT:
Novel proteins and their corresponding nucleotide sequences in enteroaggregativeEscherichia coli(EAEC) are provided. In particular, Aap and the five gene cluster (aat) of the AA probe region of the pAA plasmid of EAEC 042 have been identified, sequenced, and further characterized. The use of these novel proteins and their corresponding nucleotide sequences for diagnosis, therapy, and prevention of EAEC infections is also provided.
REFERENCES:
patent: 5189151 (1993-02-01), Baudry et al.
patent: 6436055 (2002-08-01), Roe
Bowie et al (Science, 1990, 247:1306-1310).
Burgess et al (J. of Cell Bio. 111:2129-2138, 1990).
Lazar et al. (Molecular and Cellular Biology, 1988, 8:1247-1252).
EMBL-EBI printout for Accession No. Q6V4K6 (Jul. 5, 2004).
Schmidt et al,J. of Clin. Microbiol., 33(3):701-705 (1995).
Lai et al,Microbiology, 145(Pt. 11):3295-3303 (1999).
GenEmbl Accession No. Z32523 (Oct. 31, 1994).
Nataro et al,J. of Infectious Diseases, 171(2):465-468 (1995).
Nataro et al,J. of Infectious Diseases, 152(3):560-565 (1985).
Nishi et al,J. Biolog. Chem., 278(46):45680-45689 (2003).
Sheikh et al,J. Clin. Invest., 110(9):1329-1337 (2000).
Nataro et al,Infect. Immun., 61(3):1126-1131 (1993).
Greenspan,Nature Biotechnology, 7:936-937 (1999).
Bowie,Science, 257:1306-1310 (1990).
Mullins et al,EMBO. J., 8:4065-4071 (1989).
Mullins,Hypertension,22:630-633 (1993).
Hammer,Cell, 63:1099-1112 (1990).
Taurog,J. Immunol.., 141:4020-4023 (1988).
Mullins et al,J. Clin. Invest., 97(7):1557-1560 (1996).
Houdebine,J. Biotech., 34:269-286 (1994).
Kappell,Current Opinions in Biotechnology, 3:548-552 (1992).
Cameron,Molec. Biol., 7:253-265 (1997).
Niemann,Transg. Res., 7:73-75 (1997).
Burgess et al,J. of Cell Bio., 111:2129-2137 (1990).
Lazar et al,Molecular and CellularBiology, 8:1247-1251 (1988).
Overbeek, “Factors Affecting Transgenic Animal Production”,Transgenic Animal Technology, C.A. Pinkert ed., Academic Press, Inc., pp. 96-98 (1994).
Wall,Theriogenology, 45:57-68 (1996).
Bork,Genome Res., 10:398-400 (2000).
Tzipori et al,Infect. and Immunity, 60(12):5302-5306 (1992).
Elias et al. Organization of Biogenesis Genes for Aggregative Adherence Fimbria II Defines a Virulence Gene Cluster in EnteroaggregativeEscherichia coli. J Bacteriol. Mar. 1999; 181(16): 1779-1785.
Rich et al. Characterization of EnteroaggregativeEscherichia coliisolates.FEMS Microbiol. Lett. 1999; 173, 55-61.
Nataro and Kaper. DiarrheagenicEscherichia coli. Clin Microbiol Rev. Jan. 1998; 11(1): 142-201.
University of Maryland Baltimore
Zeman Robert A
LandOfFree
Proteins in enteroaggregative Escherichia coli (EAEC)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Proteins in enteroaggregative Escherichia coli (EAEC)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Proteins in enteroaggregative Escherichia coli (EAEC)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4092793